Literature DB >> 8691147

A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2.

M Takata1, T Kurosaki.   

Abstract

Defects in the gene encoding Bruton's tyrosine kinase (Btk) result in a disease called X-linked agammaglobulinemia, in which there is a profound decrease of mature B cells due to a block in B cell development. Recent studies have shown that Btk is tyrosine phosphorylated and activated upon B cell antigen receptor (BCR) stimulation. To elucidate the functions of this kinase, we examined BCR signaling of DT40 B cells deficient in Btk. Tyrosine phosphorylation of phospholipase C (PLC)-gamma 2 upon receptor stimulation was significantly reduced in the mutant cells, leading to the loss of both BCR-coupled phosphatidylinositol hydrolysis and calcium mobilization. Pleckstrin homology and Src-homology 2 domains of Btk were required for PLC-gamma 2 activation. Since Syk is also required for the BCR-induced PLC-gamma 2 activation, our findings indicate that PLC-gamma 2 activation is regulated by Btk and Syk through their concerted actions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8691147      PMCID: PMC2192683          DOI: 10.1084/jem.184.1.31

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  61 in total

Review 1.  BTKbase: a database of XLA-causing mutations. International Study Group.

Authors:  M Vihinen; M D Cooper; G de Saint Basile; A Fischer; R A Good; R W Hendriks; C Kinnon; S P Kwan; G W Litman; L D Notarangelo
Journal:  Immunol Today       Date:  1995-10

2.  B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia.

Authors:  M de Weers; G S Brouns; S Hinshelwood; C Kinnon; R K Schuurman; R W Hendriks; J Borst
Journal:  J Biol Chem       Date:  1994-09-30       Impact factor: 5.157

3.  Binding of G protein beta gamma-subunits to pleckstrin homology domains.

Authors:  K Touhara; J Inglese; J A Pitcher; G Shaw; R J Lefkowitz
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

4.  Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate.

Authors:  J E Harlan; P J Hajduk; H S Yoon; S W Fesik
Journal:  Nature       Date:  1994-09-08       Impact factor: 49.962

Review 5.  Bruton's tyrosine kinase is a key regulator in B-cell development.

Authors:  D J Rawlings; O N Witte
Journal:  Immunol Rev       Date:  1994-04       Impact factor: 12.988

Review 6.  X-linked agammaglobulinemia and other immunoglobulin deficiencies.

Authors:  C I Smith; K B Islam; I Vorechovský; O Olerup; E Wallin; H Rabbani; B Baskin; L Hammarström
Journal:  Immunol Rev       Date:  1994-04       Impact factor: 12.988

Review 7.  Signal transduction by the B cell antigen receptor and its coreceptors.

Authors:  J C Cambier; C M Pleiman; M R Clark
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

8.  Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis.

Authors:  L A Bradley; A K Sweatman; R C Lovering; A M Jones; G Morgan; R J Levinsky; C Kinnon
Journal:  Hum Mol Genet       Date:  1994-01       Impact factor: 6.150

9.  Analysis of Ig-alpha-tyrosine kinase interaction reveals two levels of binding specificity and tyrosine phosphorylated Ig-alpha stimulation of Fyn activity.

Authors:  M R Clark; S A Johnson; J C Cambier
Journal:  EMBO J       Date:  1994-04-15       Impact factor: 11.598

10.  Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling.

Authors:  T Kurosaki; M Takata; Y Yamanashi; T Inazu; T Taniguchi; T Yamamoto; H Yamamura
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  120 in total

Review 1.  Negative signaling in health and disease.

Authors:  K M Coggeshall
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Early B cell defects.

Authors:  H B Gaspar; M E Conley
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

Review 3.  X-linked agammaglobulinemia.

Authors:  M E Conley; J Rohrer; Y Minegishi
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

Review 4.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

5.  Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein.

Authors:  T Yamadori; Y Baba; M Matsushita; S Hashimoto; M Kurosaki; T Kurosaki; T Kishimoto; S Tsukada
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

Review 6.  Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemia.

Authors:  Kumudha Balakrishnan; Varsha Gandhi
Journal:  Expert Opin Investig Drugs       Date:  2012-03-09       Impact factor: 6.206

7.  The controlling role of ATM in homologous recombinational repair of DNA damage.

Authors:  C Morrison; E Sonoda; N Takao; A Shinohara; K Yamamoto; S Takeda
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

8.  A phosphorylation site in Bruton's tyrosine kinase selectively regulates B cell calcium signaling efficiency by altering phospholipase C-gamma activation.

Authors:  Shuling Guo; Gregory Z Ferl; Rajendar Deora; Mireille Riedinger; Sheng Yin; James L Kerwin; Joseph A Loo; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-16       Impact factor: 11.205

9.  Expression and function of Tec, Itk, and Btk in lymphocytes: evidence for a unique role for Tec.

Authors:  Michael G Tomlinson; Lawrence P Kane; Jennifer Su; Theresa A Kadlecek; Marianne N Mollenauer; Arthur Weiss
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

10.  Conformation of full-length Bruton tyrosine kinase (Btk) from synchrotron X-ray solution scattering.

Authors:  José A Márquez; C I Edvard Smith; Maxim V Petoukhov; Paola Lo Surdo; Pekka T Mattsson; Marika Knekt; Anna Westlund; Klaus Scheffzek; Matti Saraste; Dmitri I Svergun
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.